Sigma Planning Corp’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,313
Closed -$385K 1430
2022
Q1
$385K Sell
3,313
-301
-8% -$35.1K 0.01% 953
2021
Q4
$544K Sell
3,614
-50
-1% -$6.75K 0.02% 817
2021
Q3
$437K Sell
3,664
-243
-6% -$26.8K 0.01% 876
2021
Q2
$381K Sell
3,907
-234
-6% -$20.9K 0.01% 960
2021
Q1
$365K Buy
4,141
+155
+4% +$14.4K 0.01% 899
2020
Q4
$381K Buy
3,986
+243
+6% +$25K 0.01% 789
2020
Q3
$425K Buy
3,743
+436
+13% +$45.8K 0.02% 661
2020
Q2
$327K Buy
+3,307
New +$264K 0.01% 744
2019
Q4
Sell
-6,784
Closed -$400K 1107
2019
Q3
$400K Sell
6,784
-271
-4% -$17.3K 0.02% 658
2019
Q2
$455K Sell
7,055
-5,675
-45% -$366K 0.02% 574
2019
Q1
$808K Buy
12,730
+5,102
+67% +$268K 0.05% 365
2018
Q4
$290K Buy
+7,628
New +$269K 0.02% 614

Other funds holding TNDM

Sigma Planning Corp's TNDM Position: Q2 2022 in Review

Sigma Planning Corp sold out of Tandem Diabetes Care (TNDM) in Q2 2022, closing a stake of 3,313 shares — an estimated $385K sold.

Sigma Planning Corp first reported a position in TNDM in Q4 2018 and held it in 12 quarters. The position peaked at $808K in Q1 2019. 330 funds tracked by Wall St. Rank hold TNDM as of Q2 2022.

  • Sigma Planning Corp reported no remaining Tandem Diabetes Care position as of Q2 2022 after selling out during the quarter.
  • Sigma Planning Corp sold 3,313 Tandem Diabetes Care shares in Q2 2022, an estimated $385K.
  • Sigma Planning Corp first reported a position in Tandem Diabetes Care in Q4 2018 and held it in 12 quarters.
  • Sigma Planning Corp's Tandem Diabetes Care position peaked at $808K in Q1 2019.
  • 330 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2022.

Based on Sigma Planning Corp's 13F filing for Q2 2022, filed 11 Aug 2022.